45
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies

, , , , , , & show all
Pages 3203-3210 | Published online: 29 Jun 2017

References

  • SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
  • QinZLiXTangJAssociation between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysisOnco Targets Ther201695451545927660462
  • JiaMDahlman-WrightKGustafssonJAEstrogen receptor alpha and beta in health and diseaseBest Pract Res Clin Endocrinol Metab201529455756826303083
  • ZhaoXZLiuYZhouLJWangZQWuZHYangXYRole of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathwaysOnco Targets Ther201582849286326491358
  • RickeWAMcPhersonSJBiancoJJCunhaGRWangYRisbridgerGPProstatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signalingFASEB J20082251512152018055862
  • KnoblochKYoonUVogtPMPreferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication biasJ Craniomaxillofac Surg2011392919221145753
  • HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions2011 Available from: http://www.cochrane-handbook.orgAccessed July 1, 2014
  • LittleJHigginsJPIoannidisJPSTrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statementEur J Clin Invest200939424726619297801
  • PetersJLSuttonAJJonesDRAbramsKRRushtonLPerformance of the trim and fill method in the presence of publication bias and between-study heterogeneityStat Med200726254544456217476644
  • ModugnoFWeissfeldJLTrumpDLAllelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer riskClin Cancer Res20017103092309611595700
  • SuzukiKNakazatoHMatsuiHGenetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese populationCancer20039871411141614508827
  • TanakaYSasakiMKaneuchiMShiinaHIgawaMDahiyaRPolymorphisms of estrogen receptor alpha in prostate cancerMol Carcinog200337420220812891629
  • FukatsuTHirokawaYArakiTGenetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese populationAnticancer Res20042442431243715330195
  • HernándezJBalicIJohnson-PaisTLAssociation between an eestrogen receptor alpha gene polymorphism and the risk of prostate cancer in black menJ Urol2006175252352716406987
  • LowYLTaylorJIGracePBPhytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer riskNutr Cancer2006561313917176215
  • BerndtSIChatterjeeNHuangWYVariant in sex hormone-binding globulin gene and the risk of prostate cancerCancer Epidemiol Biomarkers Prev200716116516817220347
  • KjaergaardADEllervikCTybjaerg-HansenAEstrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysisCirculation2007115786187117309937
  • OnsoryKSobtiRCAl-BadranAIHormone receptor-related gene polymorphisms and prostate cancer risk in North Indian populationMol Cell Biochem20083141–2253518483761
  • SobtiRCGuptaLSinghSKSethAKaurPThakurHRole of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian populationCancer Genet Cytogenet20081852788518722876
  • GuptaLThakurHSobtiRCSethASinghSKRole of genetic polymorphism of estrogen receptor-alpha gene and risk of prostate cancer in north Indian populationMol Cell Biochem20103351–225526119904497
  • BalistreriCRCarusoCCarrubaGMiceliVCandoreGGenotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary studyOMICS201115636937421348640
  • SissungTMDanesiRKirklandCTEstrogen receptor alpha and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapyJ Clin Endocrinol Metab2011962E368E37221106711
  • SzendroiASpeerGTabakAThe role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancerCan J Urol20111835710571621703046
  • SafarinejadMRSafarinejadSShafieiNSafarinejadSEstrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian menMol Carcinog201251Suppl 1E104E11722228197
  • JurecekovaJSivonovaMKEvinovaAKlimentJDobrotaDThe association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak populationMol Cell Biochem20133811–220120723737135
  • PazarbasiAYilmazMBAlptekinDGenetic polymorphisms of estrogen receptor alpha and catechol-O-methyltransferase genes in Turkish patients with familial prostate carcinomaIndian J Hum Genet201319440841124497704
  • LuXYamanoYTakahashiHAssociations between estrogen receptor genetic polymorphisms, smoking status, and prostate cancer risk: a case-control study in Japanese menEnviron Health Prev Med201520533233726251204
  • AttardGParkerCEelesRAProstate cancerLancet201638710013708226074382
  • FeiXLiuNLiHShenYGuoJWuZPolymorphisms of vitamin D receptor gene TaqI susceptibility of prostate cancer: a meta-analysisOnco Targets Ther201691033104527042096
  • SundermannEEMakiPMBishopJRA review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognitionMenopause201017487488620616674